Morgan Stanley Sticks to Its Buy Rating for British American Tobacco (BATS)

Morgan Stanley analyst David Roux maintained a Buy rating on British American Tobacco today and set a price target of p4,950.00.

Introducing TipRanks MCP for Agents

• Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
• Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.

Roux covers the Consumer Defensive sector, focusing on stocks such as Glanbia, British American Tobacco, and Coca Cola HBC. According to TipRanks, Roux has an average return of -0.8% and a 57.14% success rate on recommended stocks.

In addition to Morgan Stanley, British American Tobacco also received a Buy from Bank of America Securities’s Bastien Agaud in a report issued on June 2. However, on the same day, RBC Capital maintained a Sell rating on British American Tobacco (LSE: BATS).

Based on British American Tobacco’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p13.54 billion and a net profit of p3.25 billion. In comparison, last year the company earned a revenue of p13.53 billion and had a GAAP net loss of p1.45 billion

Based on the recent corporate insider activity of 74 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BATS in relation to earlier this year.